Low autophagy capacity implicated in motor system vulnerability to mutant superoxide dismutase

Acta Neuropathologica Communications
Eiichi TokudaS L Marklund

Abstract

The motor system is selectively vulnerable to mutations in the ubiquitously expressed aggregation-prone enzyme superoxide dismutase-1 (SOD1). Autophagy clears aggregates, and factors involved in the process were analyzed in multiple areas of the CNS from human control subjects (n = 10) and amyotrophic lateral sclerosis (ALS) patients (n = 18) with or without SOD1 mutations. In control subjects, the key regulatory protein Beclin 1 and downstream factors were remarkably scarce in spinal motor areas. In ALS patients, there was evidence of moderate autophagy activation and also dysregulation. These changes were largest in SOD1 mutation carriers. To explore consequences of low autophagy capacity, effects of a heterozygous deletion of Beclin 1 were examined in ALS mouse models expressing mutant SOD1s. This caused earlier SOD1 aggregation, onset of symptoms, motor neuron loss, and a markedly shortened survival. In contrast, the levels of soluble misfolded SOD1 species were reduced. The findings suggest that an inherent low autophagy capacity might cause the vulnerability of the motor system, and that SOD1 aggregation plays a crucial role in the pathogenesis.

References

Jul 24, 2001·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·B R BrooksUNKNOWN World Federation of Neurology Research Group on Motor Neuron Diseases
Jul 24, 2001·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·S KatoE Ohama
Mar 11, 2003·Nature Genetics·Imke PulsKenneth H Fischbeck
Oct 10, 2003·Brain : a Journal of Neurology·P Andreas JonssonStefan L Marklund
Nov 26, 2003·The Journal of Clinical Investigation·Xueping QuBeth Levine
Dec 7, 2005·Brain : a Journal of Neurology·P Andreas JonssonStefan L Marklund
Apr 21, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Daniel BergemalmStefan L Marklund
Jun 3, 2006·Science·Séverine BoilléeDon W Cleveland
Aug 25, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Thomas W GouldRonald W Oppenheim
Aug 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Per ZetterströmStefan L Marklund
Jul 4, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Barry BolandRalph A Nixon
Jul 9, 2008·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Richard WroeAmmar Al-Chalabi
Oct 29, 2008·Oncogene·P Boya, G Kroemer
Mar 3, 2009·Molecular Cell·Viktor I KorolchukDavid C Rubinsztein
Mar 10, 2009·Nature Cell Biology·Kohichi MatsunagaTamotsu Yoshimori
Apr 7, 2009·Oncogene·I A CiechomskaA M Tolkovsky
Jul 31, 2009·Oncogene·S Sinha, B Levine
Aug 5, 2009·Proceedings of the National Academy of Sciences of the United States of America·Andreas FrieseSilvia Arber
Aug 26, 2009·Neurobiology of Disease·P Andreas JonssonThomas Brännström
Dec 3, 2009·The Journal of Cell Biology·Hristelina IlievaDon W Cleveland
Dec 26, 2009·Analytical Biochemistry·Karl-Heinz StrucksbergChristoph S Clemen
Aug 12, 2010·Proceedings of the National Academy of Sciences of the United States of America·John C PriceSina Ghaemmaghami
Oct 13, 2011·Nature Reviews. Neurology·Peter M Andersen, Ammar Al-Chalabi
Jun 23, 2012·Cell Death and Differentiation·S ShaidI Dikic
Jul 17, 2012·Proceedings of the National Academy of Sciences of the United States of America·Lisa LangMikael Oliveberg
Oct 3, 2012·Human Molecular Genetics·Karin S GraffmoThomas Brännström
Oct 19, 2012·Neuromolecular Medicine·Per ZetterströmStefan L Marklund
Feb 15, 2013·The New England Journal of Medicine·Augustine M K ChoiBeth Levine
Nov 20, 2013·Experimental Neurology·John Hardy, Ekaterina Rogaeva
Feb 20, 2014·Proceedings of the National Academy of Sciences of the United States of America·Leslie I GradNeil R Cashman
Oct 2, 2014·Trends in Pharmacological Sciences·René L VidalClaudio Hetz
Feb 24, 2015·Science·Elizabeth T CirulliDavid B Goldstein

❮ Previous
Next ❯

Citations

Apr 2, 2016·Brain Research·Céline Ruegsegger, Smita Saxena
May 4, 2016·The Journal of Clinical Investigation·Elaheh Ekhtiari BidhendiThomas Brännström
Feb 2, 2018·Autophagy·Vicente ValenzuelaClaudio Hetz
Apr 16, 2018·CNS Neuroscience & Therapeutics·Jing-Jing ZhangWei-Dong Le
Oct 5, 2017·Human Molecular Genetics·Danilo B MedinasClaudio Hetz
Nov 9, 2019·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Shu YangIan P Blair
Feb 12, 2020·Medicinal Research Reviews·Heike J WobstJames Shorter
Mar 29, 2019·Molecular Neurodegeneration·S BeltranU Woehlbier
Jan 13, 2019·The Journal of Experimental Medicine·David BrennerJochen H Weishaupt
May 18, 2017·Frontiers in Molecular Neuroscience·Christopher P WebsterKurt J De Vos
Oct 5, 2018·Acta Neuropathologica·Elaheh Ekhtiari BidhendiThomas Brännström
Jul 2, 2019·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Eiichi TokudaYoshiaki Furukawa
Sep 8, 2017·Frontiers in Molecular Neuroscience·Nandini Ramesh, Udai Bhan Pandey
Jan 22, 2020·Journal of Molecular Biology·Nesibe Peker, Devrim Gozuacik
Jan 19, 2019·ACS Chemical Neuroscience·Shifan MaXiang-Qun Xie

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
PCR
filter trap
Assay
dot-blot

Software Mentioned

Quantity One
Statcel
Pannoramic Viewer

Related Concepts

Related Feeds

Autophagy Networks

Autophagy is a lysosomal pathway that involves degradation of proteins and functions in normal growth and pathological conditions, through a series of complex networks. The catabolic process involves delivery of proteins and organelles to the lysosome. Here is the latest research on autophagy networks.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.